December 10th & 11th, 2026
15th edition
MARSEILLE, FR

What are the outcomes of long-lasting commitment between universities and pharmaceutical companies?

What are the outcomes of long-lasting commitment between universities and pharmaceutical companies?

To which needs do these numerous collaboration schemes answer? What are the specificities of these agreements in terms of management models and R&D means mutualisation. Are short-term reports and industry constraints coherent with multi-years academic agreements?

Ulrik Rahbek

Vice President
Novo Nordisk

Isabelle Barlat

Strategy&Business Development-R&D Transaction Manager
SANOFI

Christopher Keely

Senior Business Development Manager
TRINITY COLLEGE DUBLIN
Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.